Sunday August 20th 2017

CD80+ and CD86+ B cells as biomarkers and possible therapeutic targets in HTLV-1 associated myelopathy/tropical spastic paraparesis and multiple…

Conclusions: We propose two novel biomarkers, ex vivo CD80+ B cells positively correlating to disease severity and CD86+ B cells preferentially induced by IFN-beta, which restores defective upregulation in HAM/TSP. This study suggests a role for B cells in HAM/TSP pathogenesis and opens avenues to B cell targeting (with proven clinical benefit in MS) in HAM/TSP but also CD80-directed immunotherapy, unprecedented in both HAM/TSP and MS. (Source: Epidemiologic Perspectives and Innovations)

Continued here: 

CD80+ and CD86+ B cells as biomarkers and possible therapeutic targets in HTLV-1 associated myelopathy/tropical spastic paraparesis and multiple…

Leave a Comment

More from category

Researchers Co-funded by National MS Society Report on New Way to Translate Lab Findings Aimed at Re
Researchers Co-funded by National MS Society Report on New Way to Translate Lab Findings Aimed at Re

/About-the-Society/News/Researchers-Co-funded-by-National-MS-Society-Repor [Read More]

U.S. House Democrats Launch Probe Into MS Drug Pricing U.S. House Democrats Launch Probe Into MS Drug Pricing
U.S. House Democrats Launch Probe Into MS Drug Pricing U.S. House Democrats Launch Probe Into MS Drug Pricing

U.S. House Democrats said on Thursday they were launching an investigation into why prices for multiple sclerosis (MS) [Read More]

MassDevice.com +5 | The top 5 medtech stories for August 18, 2017
MassDevice.com +5 | The top 5 medtech stories for August 18, 2017

Say hello to MassDevice +5, a bite-sized view of the top five medtech stories of the day. This feature of [Read More]

Investigators Recruiting for Study of ALKS 8700 vs. Dimethyl Fumarate in Relapsing-Remitting MS
Investigators Recruiting for Study of ALKS 8700 vs. Dimethyl Fumarate in Relapsing-Remitting MS

/About-the-Society/News/Investigators-Recruiting-for-Study-of-ALKS-8700-vs [Read More]

Statement on House Oversight and Government Reform Committee Action on the Pricing Strategies for MS
Statement on House Oversight and Government Reform Committee Action on the Pricing Strategies for MS

/About-the-Society/News/Statement-on-House-Oversight-and-Government-Reform [Read More]